ESALF (Eisai Co) Beginning Cash Position: $0 Mil (As of Mar. 2026)


ESALF Eisai Co Ltd ESALF
69 GF Score
Price $25.00
GF Value $35.00
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eisai Co Beginning Cash Position?

Eisai Co ESALF 69 Beginning Cash Position is $0 Mil as of Mar. 2026. GuruFocus rates ESALF with a GF Score™ of 69/100 and a GF Value™ of $35.00 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Eisai Co's Beginning Cash Position for the quarter that ended in Mar. 2026 was $0 Mil.

Eisai Co's quarterly Beginning Cash Position increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($1,935 Mil) but then declined from Dec. 2025 ($1,935 Mil) to Mar. 2026 ($0 Mil).

Eisai Co's annual Beginning Cash Position increased from Mar. 2024 ($1,784 Mil) to Mar. 2025 ($2,044 Mil) but then declined from Mar. 2025 ($2,044 Mil) to Mar. 2026 ($1,674 Mil).

Eisai Co Beginning Cash Position Related Terms

Eisai Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Eisai Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Beginning Cash Position Chart

Eisai Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,097.70 2,316.49 1,784.50 2,044.02 1,673.54

Eisai Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 1,838.00 0.01 1,934.67 0.01
ESALF
69GF Score
Eisai Co Ltd ESALF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eisai Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0 Mil mean?
Eisai Co (ESALF) has a Beginning Cash Position of $0 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Eisai Co and its competitors.
Is Eisai Co's Beginning Cash Position too high?
Eisai Co's current Beginning Cash Position is $0 Mil. Overall, Eisai Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Beginning Cash Position compare to ZTS and UTHR?
Eisai Co's Beginning Cash Position of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Eisai Co and its competitors. Eisai Co's current Beginning Cash Position is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESALF) is currently considered Modestly Undervalued. The stock's GF Value™ is $35.00, compared to a current price of $25.00 — trading 28.6% below its estimated fair value. The current Beginning Cash Position is $0 Mil. Eisai Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Eisai Co (ESALF), the current Beginning Cash Position is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eisai Co (ESALF) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of $25.00 is trading 28.6% below its estimated GF Value™ of $35.00. GuruFocus considers Eisai Co to be Modestly Undervalued.

Key valuation signals for ESALF:

  • Beginning Cash Position: $0 Mil
  • GF Value™: $35.00 vs. price of $25.00 (28.6% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the ESALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
69GF Score

Get the complete analysis for ESALF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.00
Price
$35.00
GF Value